Michael Farah

Michael Farah has been involved in principal investing and investment banking since 2001. Prior to Linden, he was a Vice President at Metalmark Capital where he focused on healthcare investing. Mr. Farah began his career at UBS Investment Bank where he focused on M&A advisory and capital raising transactions for the healthcare sector and also spent three years with Summit Partners as a private equity associate.

Mr. Farah holds a Bachelor of Arts in Finance, with honors, from Carnegie Mellon University and an MBA from Harvard Business School.

Company Blog

May 14, 2018
The Power to See Differences that Matter
What are the real-world consequences of giving inadequate consideration to power when developing a… Read More
April 24, 2018
ProPharma Group Announces New President / CEO
ProPharma Group announces today that Dawn Sherman will be joining the company as President… Read More
April 3, 2018
Understanding the New Combination Product PMSR Guidance Documents and Impact…
Take a closer look at new FDA guidance documents surrounding postmarketing safety reporting (PMSR)… Read More
More Articles

UPCOMING Events

June 04, 2018
BIO International
The BIO International Convention  attracts more than 16,000 biotechnology and pharma leaders who come togethe... Read More
June 05, 2018
DIA Pharmacovigilance Conference
Join the DIA Pharmacovigilance Conference to discuss the current landscape and join intense and well-lead dis... Read More
June 24, 2018
DIA Annual 2018
The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe. Designed to ... Read More
All Events
Contact Us